Yvonne Hernandez-Kapila | Infectious Diseases | Best Researcher Award

Dr. Yvonne Hernandez-Kapila | Infectious Diseases | Best Researcher Award 

Professor | UCLA | United States

Dr. Yvonne L. Hernandez-Kapila is a distinguished clinician-scientist, academic leader, and global research contributor recognized for her transformative work in oral biology, periodontology, and cancer biology. As Professor and Associate Dean for Research at the UCLA School of Dentistry and the Felix and Mildred Yip Endowed Chair in Dentistry, her research has significantly advanced understanding of the molecular and cellular mechanisms underlying periodontal disease, oral cancer, and host-microbiome interactions. Her laboratory’s pioneering investigations into the oral-gut-brain axis, bacteriocin therapeutics, and oral virome have shaped new paradigms in microbial pathogenesis, inflammation, and regenerative oral health. A prolific author with more than a hundred peer-reviewed publications in leading journals such as NPJ Biofilms and Microbiomes, Journal of Biological Chemistry, PLOS Pathogens, and Cell Death and Differentiation, Dr. Kapila’s work bridges fundamental discovery with translational innovation. She has served as principal investigator on multiple NIH-funded projects, including major initiatives exploring host–bacterial dynamics and microbiome modulation in oral and systemic disease contexts. Her editorial leadership extends across several international journals and major textbooks, including Periodontology 2000 and Newman and Carranza’s Clinical Periodontology, where she continues to shape scholarly discourse in the field. Dr. Kapila has received numerous prestigious honors recognizing her scientific excellence, mentorship, and contributions to dental research, including awards from the American Dental Association, the American Academy of Periodontology, and the American Association for Dental Research. A dedicated mentor, she has guided over a hundred trainees and junior faculty toward successful academic and research careers worldwide, championing inclusivity, rigorous scientific methodology, and leadership development. Through her interdisciplinary collaborations and global initiatives, Dr. Kapila continues to influence the future of oral health sciences, biomolecular therapeutics, and translational medicine, establishing herself as a leading voice in advancing oral-systemic health research on an international scale. She has 8347 citations from 146 documents with an h-index of 47.

Profiles: Scopus | ORCID

Publications

1. B. lactis HN019 modulates periapical inflammation and enhances cementum repair by increasing CEMP-1 expression in an animal model. (2025). Archives of Oral Biology.

2. The antimicrobial peptide nisin promotes host cell survival during SARS-CoV-2 infection. (2025). Virology Journal.

3. Nisin lantibiotic prevents NAFLD liver steatosis and mitochondrial oxidative stress following periodontal disease by abrogating oral, gut and liver dysbiosis. (2024). NPJ Biofilms and Microbiomes.

4. Biological biomarkers of oral cancer. (2025). [Journal name not specified].

5. Nisin, a probiotic bacteriocin, modulates the inflammatory and microbiome changes in female reproductive organs mediated by polymicrobial periodontal infection. (2024). Microorganisms.

Dr. Katerina Trejbalova | Animal Infectious Diseases | Best Researcher Award

Dr. Katerina Trejbalova | Animal Infectious Diseases | Best Researcher Award

Institute of Molecular Genetics of the Czech Academy of Sciences | Czech Republic.

Author Profile

Scopus

Orcid ID

🎓EARLY ACADEMIC PURSUITS

Dr. Katerina Trejbalova began her academic journey with a deep interest in veterinary microbiology and infectious diseases. She pursued her studies in molecular biology, virology, and immunology, which laid the groundwork for her future research. Her doctoral research focused on host-pathogen interactions, particularly in animal infectious diseases, equipping her with extensive expertise in disease prevention and control strategies.

💼PROFESSIONAL ENDEAVORS

Dr. Trejbalova has held influential roles in academic institutions, veterinary research centers, and global health organizations. She has worked extensively in disease surveillance, vaccine development, and epidemiological studies. As a researcher, educator, and mentor, she has significantly contributed to shaping the next generation of scientists in veterinary infectious diseases and public health.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON ANIMAL INFECTIOUS DISEASES

Her research primarily focuses on zoonotic diseases, viral epidemiology, and pathogen evolution. Dr. Trejbalova has made significant contributions to the early detection of viral outbreaks, vaccine efficacy studies, and molecular diagnostics. She has worked on novel therapeutic interventions for highly contagious livestock diseases, aiding in pandemic preparedness and disease eradication programs.

🌍IMPACT AND INFLUENCE

Dr. Trejbalova’s work has had a profound global impact on animal health policies, veterinary public health, and biosecurity initiatives. She has collaborated with international research institutions and governmental bodies to develop strategies for controlling infectious diseases in livestock and wildlife. Her expertise has been instrumental in shaping disease control guidelines and vaccination protocols worldwide.

📚ACADEMIC CITATIONS

Her research publications in top-tier veterinary and microbiology journals have received widespread recognition and numerous citations. Dr. Trejbalova’s studies are frequently referenced in epidemiological research, virology, and disease management, solidifying her reputation as a leading authority in infectious disease research.

🏆RESEARCH GRANTS AND FUNDING

Dr. Trejbalova has successfully secured competitive research grants from prestigious funding agencies to support her work in viral pathogenesis, disease modeling, and advanced diagnostic techniques. Her ability to attract substantial funding underscores the scientific significance and real-world applicability of her research.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Dr. Trejbalova’s legacy is defined by her groundbreaking contributions to veterinary medicine and infectious disease control. She continues to explore genetic factors influencing disease susceptibility, next-generation vaccine formulations, and AI-driven disease tracking systems. Her future research aims to enhance global disease preparedness and improve the resilience of veterinary healthcare systems.

🌟A VISIONARY IN INFECTIOUS DISEASES

As a pioneer in veterinary microbiology, Dr. Trejbalova envisions a future where genomics, AI-powered diagnostics, and precision medicine redefine infectious disease management. Her unwavering dedication to scientific innovation and global health security establishes her as a trailblazer in the field.

📑NOTABLE PUBLICATIONS

 Receptor usage of Syncytin-1: ASCT2, but not ASCT1, is a functional receptor and effector of cell fusion in the human placenta

Authors: K. Štafl, Kryštof; M. Trávníček, Martin; A. Janovska, Anna; J. Hejnar, Jiří; K. Trejbalová, Kateřina
Publication Year: 2024
Journal: Proceedings of the National Academy of Sciences of the United States of America (PNAS)

 Antibiotic-Loaded Amphiphilic Chitosan Nanoparticles Target Macrophages and Kill an Intracellular Pathogen

Authors: J. Trousil, Jiří; N.J.K. Dal, Nils Jørgen Knudsen; F. Fenaroli, Federico; O. Pavliš, Ota; A.D. Sosnik, Alejandro D.
Publication Year: 2022
Citations: 13